drugset
drugset / Trial / NCT04400201

A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy

NCT04400201 ↗

Phase 3 Completed 330 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedSingle-groupSingle-blindTreatment

Summary

A multicenter, randomized, single-blind, active controlled, parallel group study comparing remimazolam tosilate to propofol in patients undergoing bronchoscopy.

Timeline

Start
2020-06-15
Primary completion
2020-10-28
Completion
2020-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 12 mg/kg Intravenous
Subject Remimazolam Small molecule 1 mg/kg Intravenous

Indications

No indication recorded.